Cancer Research UK logo.
SearchDonate
  • Search

A study of venetoclax and ibrutinib for chronic lymphocytic leukaemia (CLARITY)

Overview

Cancer types:

Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia

Status:

Results

Phase:

Phase 2

Details

This study was for people with chronic lymphocytic leukaemia (CLL) that had come back after treatment, or treatment had stopped working.

It was open for people to join between 2016 and 2017, and the team published the results in 2019.

Recruitment start: 20 May 2016

Recruitment end: 30 November 2017

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Peter Hillmen

Supported by

University of Birmingham

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Janssen-Cilag

Abbvie

Blood Cancer UK

Last reviewed: 22 Feb 2021

CRUK internal database number: 13896

Help and support